Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADRN Barrier/Immunoprofiling Exploratory Pilot Study (ADRN-04)

NCT02115399 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT02115399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02115399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADRN Barrier/Immunoprofiling Exploratory Pilot Study (ADRN-04)
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
June 30, 2015
Enrollment
150 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, dermatitis, atopic, eczema, non-atopic healthy controls